Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes

OBJECTIVE: To determine the effect of tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 receptors, on biomarkers of nonalcoholic steatohepatitis (NASH) and fibrosis in patients with type 2 diabetes mellitus (T2DM). RESEARCH DESIGN AND METHODS: Pa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Care
Hlavní autoři: Hartman, Mark L., Sanyal, Arun J., Loomba, Rohit, Wilson, Jonathan M., Nikooienejad, Amir, Bray, Ross, Karanikas, Chrisanthi A., Duffin, Kevin L., Robins, Deborah A., Haupt, Axel
Médium: Artigo
Jazyk:Inglês
Vydáno: American Diabetes Association 2020
Témata:
Novel Communications in Diabetes
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7245348/
https://ncbi.nlm.nih.gov/pubmed/32291277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc19-1892
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky